![Sumeet Ambarkhane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sumeet Ambarkhane formerly worked at LAVA Therapeutics NV, as Executive Medical Director from 2021 to 2022, MorphoSys AG, as Head-Medical & Clinical Strategy, and Alligator Bioscience AB, as Chief Medical Officer from 2022 to 2025.
Dr. Ambarkhane received his doctorate degree from King Edward Memorial Hospital.
| Sociétés | Poste | Fin |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Directeur Technique/Scientifique/R&D | 31/03/2025 |
| LAVA THERAPEUTICS N.V. | Directeur Technique/Scientifique/R&D | 01/01/2022 |
| MORPHOSYS AG | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Alligator Bioscience AB
 Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
King Edward Memorial Hospital
 King Edward Memorial Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LAVA Therapeutics NV
 LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
